Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gruber

Showing results (281-290 of 355) with videos related to

Pageof 36
Sort By:
Pediatrics|March 1, 1997
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study GroupW J Rodriguez, W C Gruber, R C Welliver, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 1, 2014
Predicting pneumococcal community-acquired pneumonia in the emergency department: evaluation of clinical parametersS M Huijts, W G Boersma, D E Grobbee, et al.
The Journal of Infectious Diseases|October 12, 2021
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis VaccineJames T Peterson, Agnieszka M Zareba, David Fitz-Patrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2021
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 YearsBrandon Essink, Charu Sabharwal, Kevin Cannon, et al.
The Journal of Infectious Diseases|December 21, 2021
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F VaccineEdward E Walsh, Ann R Falsey, Daniel A Scott, et al.
Biomacromolecules|May 31, 2013
Fusion of binding domains to Thermobifida cellulosilytica cutinase to tune sorption characteristics and enhancing PET hydrolysisDoris Ribitsch, Antonio Orcal Yebra, Sabine Zitzenbacher, et al.
Vaccine|January 13, 2006
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlersShabir A Madhi, Clare Cutland, Yuwei Zhu, et al.
Vaccine|June 28, 2011
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccineFrancisco Gimenez-Sanchez, Dorothee M Kieninger, Kathrin Kueper, et al.
Vaccine|September 6, 2013
Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in SpainJavier Diez-Domingo, Alejandra Gurtman, Enrique Bernaola, et al.
The Pediatric Infectious Disease Journal|November 30, 2012
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine vaccines in IndiaYeshwant K Amdekar, Sanjay K Lalwani, Ashish Bavdekar, et al.
Pageof 36

Showing results (281-290 of 355) with videos related to

Sort By:
Pageof 36
Pediatrics|March 1, 1997
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study GroupW J Rodriguez, W C Gruber, R C Welliver, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 1, 2014
Predicting pneumococcal community-acquired pneumonia in the emergency department: evaluation of clinical parametersS M Huijts, W G Boersma, D E Grobbee, et al.
The Journal of Infectious Diseases|October 12, 2021
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis VaccineJames T Peterson, Agnieszka M Zareba, David Fitz-Patrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2021
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 YearsBrandon Essink, Charu Sabharwal, Kevin Cannon, et al.
The Journal of Infectious Diseases|December 21, 2021
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F VaccineEdward E Walsh, Ann R Falsey, Daniel A Scott, et al.
Biomacromolecules|May 31, 2013
Fusion of binding domains to Thermobifida cellulosilytica cutinase to tune sorption characteristics and enhancing PET hydrolysisDoris Ribitsch, Antonio Orcal Yebra, Sabine Zitzenbacher, et al.
Vaccine|January 13, 2006
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlersShabir A Madhi, Clare Cutland, Yuwei Zhu, et al.
Vaccine|June 28, 2011
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccineFrancisco Gimenez-Sanchez, Dorothee M Kieninger, Kathrin Kueper, et al.
Vaccine|September 6, 2013
Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in SpainJavier Diez-Domingo, Alejandra Gurtman, Enrique Bernaola, et al.
The Pediatric Infectious Disease Journal|November 30, 2012
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine vaccines in IndiaYeshwant K Amdekar, Sanjay K Lalwani, Ashish Bavdekar, et al.
Pageof 36